KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Research & Development: 2017-2024

Historic Research & Development for Adaptive Biotechnologies (ADPT) over the last 8 years, with Dec 2024 value amounting to $103.0 million.

  • Adaptive Biotechnologies' Research & Development fell 2.04% to $23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.2 million, marking a year-over-year decrease of 12.27%. This contributed to the annual value of $103.0 million for FY2024, which is 15.69% down from last year.
  • According to the latest figures from FY2024, Adaptive Biotechnologies' Research & Development is $103.0 million, which was down 15.69% from $122.1 million recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Research & Development ranged from a high of $142.3 million in FY2021 and a low of $103.0 million during FY2024.
  • For the 3-year period, Adaptive Biotechnologies' Research & Development averaged around $122.3 million, with its median value being $122.1 million (2023).
  • As far as peak fluctuations go, Adaptive Biotechnologies' Research & Development skyrocketed by 64.16% in 2020, and later dropped by 15.69% in 2024.
  • Over the past 5 years, Adaptive Biotechnologies' Research & Development (Yearly) stood at $116.1 million in 2020, then rose by 22.63% to $142.3 million in 2021, then decreased by 0.41% to $141.8 million in 2022, then decreased by 13.85% to $122.1 million in 2023, then decreased by 15.69% to $103.0 million in 2024.